top of page
Medvin icon
Medvin Clinical Research

Call Toll Free:
 1 (855) MEDVIN-1

  • Instagram
  • Facebook
  • LinkedIn
Rheumatoid Arthritis.png

Rheumatoid Arthritis Trial

We are conducting a clinical trial to assess the effectiveness and safety of a novel treatment approach for individuals diagnosed with rheumatoid arthritis (RA). Rheumatoid arthritis is a chronic autoimmune disease characterized by joint inflammation, pain, and stiffness. This study aims to evaluate the potential of a new therapy in managing the symptoms and improving the quality of life for RA patients.

Trial Details

participating criteria.png

Participation Criteria

  • Must be at least 40 years of age or older. 

  • Must have knee OA of a certain severity (you will be asked to rate your pain, mobility, and other symptoms). 

  • Must not have Fibromyalgia or any other type of Arthritis.

locations.png

Participating Locations

  • Covina

  • Whittier

  • Tujunga

  • Menifee

  • Apple Valley

  • Riverside

Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Rheumatoid Arthritis?
Do you currently have any pain and/or tenderness in your joints?
Do you have a diagnosis of any other inflammatory disease other than RA?
Do you have any history of cancer in the past 5 years?
Site Preference (Select up to 2)
Do you have a confirmed diagnosis of Rheumatoid Arthritis?
Do you currently have any pain and/or tenderness in your joints?
Do you have a diagnosis of any other inflammatory disease other than RA?
Do you have any history of cancer in the past 5 years?
participating criteria.png

Participation  Criteria

  • Must be at least 40 years of age or older. 

  • Must have knee OA of a certain severity (you will be asked to rate your pain, mobility, and other symptoms). 

  • Must not have Fibromyalgia or any other type of Arthritis.

locations.png

Participating Locations

  • Covina

  • Whittier

  • Tujunga

  • Menifee

  • Apple Valley

  • Riverside

Trial Details

Rheumatoid Arthritis.png

Rheumatoid Arthritis Trial

We are conducting a clinical trial to assess the effectiveness and safety of a novel treatment approach for individuals diagnosed with rheumatoid arthritis (RA). Rheumatoid arthritis is a chronic autoimmune disease characterized by joint inflammation, pain, and stiffness. This study aims to evaluate the potential of a new therapy in managing the symptoms and improving the quality of life for RA patients.

bottom of page